Infinity Pharmaceuticals, Inc.
INFIQ
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -68.63% | -61.67% | -52.54% | -47.63% | -41.83% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -32.54% | -15.94% | 25.02% | 9.36% | 30.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -3.08% | 9.67% | 40.35% | 79.91% | -1.02% |
| Total Current Assets | -66.60% | -59.54% | -51.01% | -46.32% | -40.20% |
|
|
|||||
| Total Current Assets | -66.60% | -59.54% | -51.01% | -46.32% | -40.20% |
| Net Property, Plant & Equipment | -43.17% | -38.88% | -35.05% | -32.01% | -29.87% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -29.45% | -18.68% | 66.04% | 185.26% | 66.50% |
| Total Assets | -65.68% | -58.73% | -50.28% | -45.47% | -39.71% |
|
|
|||||
| Total Accounts Payable | -17.15% | -3.44% | 89.87% | 8.14% | 90.04% |
| Total Accrued Expenses | -20.95% | -24.95% | -22.50% | 18.27% | 33.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.37% | 29.38% | 27.90% | 2.82% | 13.34% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -15.87% | -15.72% | 2.47% | 14.97% | 35.86% |
|
|
|||||
| Total Current Liabilities | -15.87% | -15.72% | 2.47% | 14.97% | 35.86% |
| Long-Term Debt | -2.88% | -3.30% | -3.11% | -2.36% | -2.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -78.89% | -64.67% | -54.46% | -46.72% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -20.83% | -86.30% | -79.62% | -84.12% |
| Total Liabilities | -6.87% | -6.91% | -3.18% | -0.01% | 3.12% |
|
|
|||||
| Common Stock & APIC | 0.55% | 0.56% | 0.45% | 0.45% | 0.50% |
| Retained Earnings | -4.90% | -5.22% | -5.47% | -5.85% | -5.93% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3,279.04% | -383.73% | -188.32% | -133.83% | -102.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3,279.04% | -383.73% | -188.32% | -133.83% | -102.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3,279.04% | -383.73% | -188.32% | -133.83% | -102.66% |
|
|
|||||